CR20230257A - Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d - Google Patents

Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d

Info

Publication number
CR20230257A
CR20230257A CR20230257A CR20230257A CR20230257A CR 20230257 A CR20230257 A CR 20230257A CR 20230257 A CR20230257 A CR 20230257A CR 20230257 A CR20230257 A CR 20230257A CR 20230257 A CR20230257 A CR 20230257A
Authority
CR
Costa Rica
Prior art keywords
inducing
dicarboxylic acid
analgesic effect
acid esters
methods
Prior art date
Application number
CR20230257A
Other languages
English (en)
Inventor
Elzbieta Izbicka
Robert T Streeper
Original Assignee
New Frontier Labs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Frontier Labs Llc filed Critical New Frontier Labs Llc
Publication of CR20230257A publication Critical patent/CR20230257A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La divulgación provee composiciones y métodos de tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa D (PLD). En particular, los métodos incluyen la administración, a un sujeto en necesidad, de una composición farmacéutica que comprende un éster de ácido dicarboxílico
CR20230257A 2020-12-16 2021-12-16 Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d CR20230257A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063126374P 2020-12-16 2020-12-16
PCT/IB2021/061874 WO2022130290A1 (en) 2020-12-16 2021-12-16 Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase d toxin

Publications (1)

Publication Number Publication Date
CR20230257A true CR20230257A (es) 2023-10-11

Family

ID=81942875

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20230257A CR20230257A (es) 2020-12-16 2021-12-16 Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d

Country Status (9)

Country Link
US (1) US11918555B2 (es)
EP (1) EP4262780A1 (es)
CL (1) CL2023001739A1 (es)
CO (1) CO2023007955A2 (es)
CR (1) CR20230257A (es)
EC (1) ECSP23052429A (es)
MX (1) MX2023006727A (es)
PE (1) PE20232040A1 (es)
WO (1) WO2022130290A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
JP2007055988A (ja) 2005-08-23 2007-03-08 Mayumi Hirozawa スーパー虫さされ治療薬
US20120251525A1 (en) * 2009-06-30 2012-10-04 Streeper Robert T Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
WO2013030768A1 (en) 2011-08-29 2013-03-07 Orna Levin Method and composition for treating lice infestation
BR102013031043B1 (pt) 2013-12-02 2018-03-13 Fundação Butantan Uso de compostos químicos capazes de inibir a ação tóxica das esfingomielinases d do veneno de aranhas loxosceles e composição farmacêutica compreendendo os referidos compostos

Also Published As

Publication number Publication date
ECSP23052429A (es) 2023-08-31
PE20232040A1 (es) 2023-12-21
WO2022130290A1 (en) 2022-06-23
US11918555B2 (en) 2024-03-05
CO2023007955A2 (es) 2023-06-30
EP4262780A1 (en) 2023-10-25
CL2023001739A1 (es) 2024-01-19
MX2023006727A (es) 2023-06-26
US20220184024A1 (en) 2022-06-16

Similar Documents

Publication Publication Date Title
ZA202110659B (en) Methods of reducing the risk of cardiovascular events in a subject
PH12021550328A1 (en) Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject
EP4338805A3 (en) Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
PH12012500765A1 (en) Boronic acids and esters as inhibitors of fatty acid amide hydrolase
MX2011008448A (es) Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
MX2022005467A (es) Métodos para reducir el riesgo de eventos cardiovasculares en un sujeto con fibrilación auricular y/o aleteo auricular.
MX346961B (es) Formulaciones farmaceuticas que contienen corticosteroides para la administracion topica.
DE602004017705D1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
MX2009009838A (es) Esteres de acidos grasos de glucocorticoides como agentes antiinflamatorios y anti-cancer.
MX2013006877A (es) Composiciones farmaceuticas para inhibidores selectivos del factor xa para administracion oral.
CR20230257A (es) Ésteres de ácidos dicarboxílicos para el tratamiento de enfermedades y padecimientos asociados con la toxina fosfolipasa d
MX2023006728A (es) Esteres de acido dicarboxilico para inducir un efecto analgesico.
MX2015010594A (es) Esteres de testosterona de cadena larga lipobalanceados para suministro oral.
PH12021500016A1 (en) Methods of reducing the risk of cardiovascular events in a subject
EA202190859A8 (ru) Способы снижения риска сердечно-сосудистых событий у субъекта
AR075414A1 (es) Composiciones y metodos para terapia extendida con aminopiridinas